CamKII drug
Evidence from:
primary |
all sources
Related entities (30)
Mentioned in (34)
Papers in which this entity is mentioned.
- Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
- Activation of the anterior cingulate cortex ameliorates anxiety in a preclinical model of fetal alcohol spectrum disorders. (2022)
- TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease. (2020)
- Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview. (2020)
- PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome. (2020)
- Transient Potassium Channels: Therapeutic Targets for Brain Disorders. (2019)
- SK Channel Modulates Synaptic Plasticity by Tuning CaMKIIα/β Dynamics. (2019)
- Prenatal Environment That Affects Neuronal Migration. (2019)
- Diving into the world of alcohol teratogenesis: a review of zebrafish models of fetal alcohol spectrum disorder. (2018)
- Activity-dependent Signaling and Epigenetic Abnormalities in Mice Exposed to Postnatal Ethanol. (2018)
- Wnt5a is essential for hippocampal dendritic maintenance and spatial learning and memory in adult mice. (2017)
- ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease. (2017)
- Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders. (2017)
- Transcriptome Profiling Identifies Ribosome Biogenesis as a Target of Alcohol Teratogenicity and Vulnerability during Early Embryogenesis. (2017)
- Increasing the GluN2A/GluN2B Ratio in Neurons of the Mouse Basal and Lateral Amygdala Inhibits the Modification of an Existing Fear Memory Trace. (2016)
- Branch-specific dendritic Ca(2+) spikes cause persistent synaptic plasticity. (2015)
- High-throughput transcriptome sequencing identifies candidate genetic modifiers of vulnerability to fetal alcohol spectrum disorders. (2014)
- An evolutionarily conserved mechanism of calcium-dependent neurotoxicity in a zebrafish model of fetal alcohol spectrum disorders. (2014)
- Genomic factors that shape craniofacial outcome and neural crest vulnerability in FASD. (2014)
- Neural crest development in fetal alcohol syndrome. (2014)
- Epigenetics, microRNA, and addiction. (2014)
- Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. (2013)
- Bridging animal and human models of exercise-induced brain plasticity. (2013)
- The ubiquitin-proteasome system as a critical regulator of synaptic plasticity and long-term memory formation. (2013)
- Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. (2011)
- Fetal alcohol spectrum disorders and abnormal neuronal plasticity. (2011)
- Calcium-mediated repression of β-catenin and its transcriptional signaling mediates neural crest cell death in an avian model of fetal alcohol syndrome. (2011)
- Transcriptional and epigenetic mechanisms of addiction. (2011)
- Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. (2010)
- Neurotoxic effects and biomarkers of lead exposure: a review. (2009)
- DNA methylation and methyl-CpG binding proteins: developmental requirements and function. (2009)
- Protein kinases and addiction. (2008)
- Neonatal alcohol exposure induces long-lasting impairment of visual cortical plasticity in ferrets. (2003)
- Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. (1998)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| camkii | gene | 28 | 71 |
| camkii | drug | 12 | 16 |
| calcium/calmodulin-dependent protein kinase ii | drug | 1 | 1 |
| camk2 | drug | — | — |
| camkii family | drug | — | — |
| type ii camk | drug | — | — |